BACCARANI, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 15327
EU - Europa 4321
AS - Asia 1095
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 1
Totale 20764
Nazione #
US - Stati Uniti d'America 15236
UA - Ucraina 1629
DE - Germania 1174
CN - Cina 762
IT - Italia 681
FI - Finlandia 506
TR - Turchia 167
SE - Svezia 161
CA - Canada 88
VN - Vietnam 69
GB - Regno Unito 57
IR - Iran 49
FR - Francia 43
RU - Federazione Russa 38
IN - India 34
EU - Europa 20
BE - Belgio 16
NL - Olanda 8
TW - Taiwan 6
KR - Corea 5
PL - Polonia 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
ES - Italia 2
PA - Panama 2
CL - Cile 1
MD - Moldavia 1
MX - Messico 1
TH - Thailandia 1
Totale 20764
Città #
Fairfield 2732
Woodbridge 1801
Houston 1288
Jacksonville 1149
Ashburn 1102
Wilmington 1068
Seattle 1035
Cambridge 976
Ann Arbor 904
Dearborn 756
Udine 471
Beijing 372
Chandler 325
Princeton 325
Izmir 163
San Diego 151
Hefei 76
Dong Ket 69
Ottawa 68
Norwalk 56
Nanjing 48
Kunming 45
Redmond 25
Jinan 23
Guangzhou 21
Nanchang 21
Augusta 20
Leawood 20
Grafing 19
Ardabil 18
Brussels 16
Monmouth Junction 16
San Mateo 16
Chengdu 15
Toronto 15
Fuzhou 14
Helsinki 13
Zanjan 13
Simi Valley 12
Phoenix 9
Ningbo 8
Redwood City 8
Shenyang 8
Hebei 7
Rome 7
Xian 7
Auburn Hills 6
Milan 6
Saint Petersburg 6
Shaoxing 6
Zhengzhou 6
Andover 5
Changsha 5
Murano 5
Sacramento 5
Taipei 5
Trieste 5
Wuhan 5
Baotou 4
Chongqing 4
Indiana 4
Shanghai 4
Taizhou 4
Venezia 4
Bologna 3
Dallas 3
Henderson 3
Kraków 3
Mumbai 3
Shenzhen 3
Torino 3
Agugliano 2
Bengaluru 2
Chaoyang 2
Falls Church 2
Fremont 2
Hangzhou 2
Huzhou 2
Kish 2
Latina 2
Maserada Sul Piave 2
Messina 2
Modena 2
Montréal 2
Mountain View 2
Nanning 2
Nashua 2
New Delhi 2
New York 2
Palermo 2
Quzhou 2
Résia 2
Torre Del Greco 2
Wenzhou 2
Adria 1
Algund 1
Amsterdam 1
Aquiléia 1
Bassano Del Grappa 1
Binasco 1
Totale 15493
Nome #
null 220
In vitro functional assessment of a porcine hepatocytes based bioartificial liver 178
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 151
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European liver transplant registry 137
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 136
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 133
La splenectomia laparotomica e laparoscopica 131
A comparative prospective study of two available solutions for kidney and liver preservation 129
A single-center experience of late retransplantation of the liver. 128
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 123
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation 123
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 122
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 118
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 118
BENEFIT OF LAPAROSCOPY FOR RECTAL RESECTION IN PATIENTS OPERATED SIMULTANEOUSLY FOR SYNCHRONOUS LIVER METASTASES: PRELIMINARY EXPERIENCE. 117
Impact of new treatment options for hepatitis c virus infection in liver transplantation 115
Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection 114
A Matched Pair Analysis of Multicenter Long-term Follow-up after Split Liver Transplantation with Extended Right Grafts 113
Transarterial chemoembolization does not harm the hepatic artery at transplantation 113
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 112
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen 111
Liver transplantation from old donors into HCV and non-HCV recipients 110
Future of minimally invasive surgery 108
Quality-of-life assessment before and after liver transplantation. 108
Donor safety in living donor liver donation: An Italian multicenter survey 108
Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation. 108
Laparoscopic treatment of symptomatic lymphoceles after kidney transplantation 107
null 107
Diaphragm rupture in a liver transplant patient under chronic immunosuppressive therapy with sirolimus: rare complication after liver transplantation 106
Differential proteomic analysis of hepatocellular carcinoma 106
Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool 104
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 103
Technical solutions for venous outflow reconstruction in damaged liver grafts during procurement: Case reports 102
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 102
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study 102
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 100
Split and whole liver transplantation outcomes: A comparative cohort study 98
Isolation of Human Hepatocytes from Livers Rejected for Liver Transplantation on a National Basis: Results of a 2 Year-Experience 98
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 98
Liver Transplant in Patients with HIV: Infection Risk Associated with HIV and Post-transplant Immunosuppression 97
Long-term placement of subcutaneous Rusch-type stents for double biliary stenosis in a living-donor liver transplant recipient 96
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 96
Steatotic versus cirrhotic livers as a source for human hepatocyte isolation 96
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 96
IMMUNESUPPRESSION AND CANCER: A COMPARISON OF RISKS IN RECIPIENTS OF ORGAN TRANSPLANTS AND HIV-POSITIVE INDIVIDUALS 96
TREATMENT OF RECURRENT SYMPTOMATIC LYMPHOCELE AFTER KIDNEY TRANSPLANTATION WITH INTRAPERITONEAL TENCKHOFF CATHETER 96
Development of Small Bowel Volvulus on Barbed V-Loc™ Suture: A Rare Complication after Laparoscopic Ventral Rectopexy 96
Laparoscopic versus open splenectomy in the management of splenomegaly: our preliminary experience 95
Perioperative intra- and extravascular volume in liver transplant recipients. 95
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 95
Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization 95
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 94
Selective bilirubin Removal by Plasma Treatment With Plasorba BR-350 for Early Cholestatic Graft Dysfunction 94
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 94
Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications 94
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 94
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 93
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial 93
Early post-liver transplant surgical morbidity in HIV infected recipients: risk factor for overall survival? A nationwide retrospective study 93
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 93
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 92
Liver resection for hepatocellular carcinoma: A multivariate analysis of factors associated with improved prognosis. The role of clinical, pathological and surgical related factors 92
Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. 92
Pros and cons of liver transplantation in human immunodeficiency virus infected recipients 92
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 92
De Novo Solid Tumors after Kidney Transplantation: Is It Time for a Patient-Tailored Risk Assessment? Experience from a Single Center 92
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 91
RENAL ALLOGRAFT PROTECTION WITH EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ADMINISTRATION 91
Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant recipients 90
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 89
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient 89
MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients 89
Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application 88
Hepatocyte isolation using human livers discarded from transplantation: Analysis of cell yield and function 87
Acute pancreatitis after kidney transplantation. 87
Right lobe living related graft loss due to intrahepatic multiple arterio-portal fistulas. 87
Tacrolimus Therapeutic Drug Monitoring in Stable Kidney Transplantation and Individuation of CYP3A5 Genotype 87
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals 86
Transient ischemic attack after rizatriptan administration in a liver transplant recipient: A case report 86
Differential Proteomic Analysis of Hepatocellular Carcinoma 86
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation 86
Detection of transplant renal artery stenosis with contrast-enhanced ultrasound 86
In search of a pathogenesis for impaired liver regeneration post major hepatectomy with extrahepatic bile duct resection: the plot thickens! 86
DE NOVO GASTROINTESTINAL TUMOURS AFTER RENAL TRANSPLANTATION: ROLE OF CMV AND EBV VIRUSES 85
Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. 85
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center 84
Graft vessel wall pathology in a case of hepatic artery pseudo-aneurysm in a liver transplant recipient 84
De novo malignancies after liver and kidney transplantations: A single center experience on 582 consecutive cases. 84
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 84
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 84
Donor spleen cell isolation for augmentation of donor-cell chimerism in organ transplantation 83
COMBINED APPROACH FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCINOMA 83
Appendicectomy and Crohn's disease: clinical and genetic associations 83
Head and neck and esophageal cancers after liver transplant: Results from a multicenter cohort study. Italy, 1997-2010 83
null 83
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis 82
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 82
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. 82
RENOPROTECTIVE EFFECT OF EARLY INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM IN RENAL TRANSPLANT RECIPIENTS 82
Redox proteomics and immunohistology to study molecular events during ischemia-reperfusion in human liver 82
Totale 10066
Categoria #
all - tutte 30338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181045 0000 0156 102532 441321069
2018/20193033 2622318332 1917 27302 184211053712
2019/20207660 4064012841079 6291202 922859 591617231439
2020/20214329 117471138469 284501 315531 588169509237
2021/20222508 10927671126 3696 168133 34469599391
2022/2023702 3562154190 00 00 0000
Totale 21196